Found: 78
Select item for more details and to access through your institution.
Effects of vitamin D supplementation on a deep learning–based mammographic evaluation in SWOG S0812.
- Published in:
- JNCI Cancer Spectrum, 2024, v. 8, n. 4, p. 1, doi. 10.1093/jncics/pkae042
- By:
- Publication type:
- Article
A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 6, p. 1525, doi. 10.1007/s00520-012-1688-0
- By:
- Publication type:
- Article
Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cancer screening with multicancer detection tests: A translational science review.
- Published in:
- CA: A Cancer Journal for Clinicians, 2024, v. 74, n. 4, p. 368, doi. 10.3322/caac.21833
- By:
- Publication type:
- Article
Multilevel modeling and value of information in clinical trial decision support.
- Published in:
- BMC Systems Biology, 2014, v. 8, n. 1, p. 157, doi. 10.1186/s12918-014-0140-0
- By:
- Publication type:
- Article
Vitamin E and the Risk of Prostate Cancer.
- Published in:
- JAMA: Journal of the American Medical Association, 2011, v. 306, n. 14, p. 1549, doi. 10.1001/jama.2011.1437
- By:
- Publication type:
- Article
Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers.
- Published in:
- JAMA: Journal of the American Medical Association, 2009, v. 301, n. 1, p. 39, doi. 10.1001/jama.2008.864
- By:
- Publication type:
- Article
Organizational and physician factors associated with patient enrollment in cancer clinical trials.
- Published in:
- Clinical Trials, 2014, v. 11, n. 5, p. 565, doi. 10.1177/1740774514536000
- By:
- Publication type:
- Article
Moving a randomized clinical trial into an observational cohort.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 131, doi. 10.1177/1740774512460345
- By:
- Publication type:
- Article
Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
- Published in:
- Clinical Trials, 2005, v. 2, n. 5, p. 436, doi. 10.1191/1740774505cn111oa
- By:
- Publication type:
- Article
Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 15, p. 1132, doi. 10.1093/jnci/djt174
- By:
- Publication type:
- Article
Accrual to Clinical Trials: Let’s Look at the Physicians.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Introduction.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, n. 37, p. 1, doi. 10.1093/jncimonographs/lgm001
- By:
- Publication type:
- Article
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 2, p. 94, doi. 10.1093/jnci/dji009
- By:
- Publication type:
- Article
Racial/Ethnic Differences in Comprehension of Biospecimen Collection: a Nationwide University of Rochester Cancer Center NCI Community Oncology Research Program Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Age‐related macular degeneration in a randomized trial of selenium and vitamin E in men: the Select Eye Endpoints (SEE) study (SWOG S0000B).
- Published in:
- Acta Ophthalmologica (1755375X), 2021, v. 99, n. 2, p. e285, doi. 10.1111/aos.14538
- By:
- Publication type:
- Article
A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 4, p. 612, doi. 10.1038/s41416-023-02307-w
- By:
- Publication type:
- Article
Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAE.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Concordance with BRCA1/2 testing guidelines among women in The Health of Women (HOW) Study<sup>®</sup>.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 173, n. 3, p. 719, doi. 10.1007/s10549-018-5035-0
- By:
- Publication type:
- Article
Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 172, n. 3, p. 603, doi. 10.1007/s10549-018-4946-0
- By:
- Publication type:
- Article
Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screening.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 8, p. 1280, doi. 10.1093/jnci/djae083
- By:
- Publication type:
- Article
Study Design Considerations for Trials to Evaluate Multi-Cancer Early Detection Assays for Clinical Utility.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 3, p. 250, doi. 10.1093/jnci/djac218
- By:
- Publication type:
- Article
Longitudinal Changes in Cognitive Function in a Nationwide Cohort Study of Patients With Lymphoma Treated With Chemotherapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
"When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).
- Published in:
- 2014
- By:
- Publication type:
- journal article
Cancer Treatment–Related Cardiotoxicity: Current State of Knowledge and Future Research Priorities.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 9, p. 1, doi. 10.1093/jnci/dju232
- By:
- Publication type:
- Article
Development of the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 9, p. 1, doi. 10.1093/jnci/dju244
- By:
- Publication type:
- Article
Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 7, p. 1, doi. 10.1093/jnci/dju129
- By:
- Publication type:
- Article
Phase I/Ib study of olaparib and carboplatin in BRCA1 or BRCA2 mutation-associated breast or ovarian cancer with biomarker analyses.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Phase l/lb Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 6, p. 1, doi. 10.1093/jnci/dju089
- By:
- Publication type:
- Article
Baseline Selenium Status and Effects of Selenium and Vitamin E Supplementation on Prostate Cancer Risk.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 3, p. 1, doi. 10.1093/jnci/djt456
- By:
- Publication type:
- Article
Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
- Published in:
- Quality of Life Research, 2014, v. 23, n. 1, p. 257, doi. 10.1007/s11136-013-0470-1
- By:
- Publication type:
- Article
Reducing Overtreatment in Gynecologic Oncology: The Case for Less in endometrial and Ovarian Cancer.
- Published in:
- Frontiers in Oncology, 2016, p. 1, doi. 10.3389/fonc.2016.00118
- By:
- Publication type:
- Article
The end of the Hysterectomy epidemic and endometrial Cancer incidence: what Are the Unintended Consequences of Declining Hysterectomy Rates?
- Published in:
- Frontiers in Oncology, 2016, p. 1, doi. 10.3389/fonc.2016.00089
- By:
- Publication type:
- Article
Breast cancer risk prediction models and subsequent tumor characteristics.
- Published in:
- Breast Cancer (13406868), 2020, v. 27, n. 4, p. 662, doi. 10.1007/s12282-020-01060-9
- By:
- Publication type:
- Article
Changing Hearts and Minds: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 1, p. 1, doi. 10.1007/s11912-019-0751-0
- By:
- Publication type:
- Article
A randomized controlled trial of vitamin E and selenium on rate of decline in lung function.
- Published in:
- Respiratory Research, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s12931-015-0195-5
- By:
- Publication type:
- Article
A randomized controlled trial of vitamin E and selenium on rate of decline in lung function.
- Published in:
- 2015
- By:
- Publication type:
- journal article
PLCOjs, a FAIR GWAS web SDK for the NCI Prostate, Lung, Colorectal and Ovarian Cancer Genetic Atlas project.
- Published in:
- Bioinformatics, 2022, v. 38, n. 18, p. 4434, doi. 10.1093/bioinformatics/btac531
- By:
- Publication type:
- Article
Determinants of Implementation Effectiveness.
- Published in:
- Medical Care Research & Review, 2007, v. 64, n. 3, p. 279, doi. 10.1177/1077558707299887
- By:
- Publication type:
- Article
Feasibility Assessment of Using the Complete Patient‐Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO‐CTCAE) Item Library.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. e146, doi. 10.1634/theoncologist.2018-0332
- By:
- Publication type:
- Article
Learning from Experience.
- Published in:
- Oncologist, 2009, v. 14, n. 5, p. 476, doi. 10.1634/theoncologist.2009-0073
- By:
- Publication type:
- Article
Intraperitoneal Chemotherapy for Women with Epithelial Ovarian Cancer.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 403, doi. 10.1634/theoncologist.2007-0058
- By:
- Publication type:
- Article
Prevention of cisplatin‐induced hearing loss in children: Informing the design of future clinical trials.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 7, p. 2951, doi. 10.1002/cam4.1563
- By:
- Publication type:
- Article